Clinical Trial Update: A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended

View source ↗

Summary

A non-interventional study assessing the clinical benefit and effectiveness of quetiapine fumarate extended-release in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine Fumarate Extended Release (quetiapine fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED